欧林生物：高级管理人员减持股份计划公告

Core Points - Olin Bio announced that as of the disclosure date, the financial officer and vice president, Mr. Tan Yong, holds 571,440 shares, accounting for 0.14% of the total share capital [1] - The company’s secretary of the board and vice president, Mr. Wu Wei, holds 778,400 shares, representing 0.19% of the total share capital [1] - Both executives plan to reduce their holdings through centralized bidding, with Mr. Tan Yong intending to sell up to 128,860 shares and Mr. Wu Wei up to 178,500 shares within three months after the announcement, starting 15 trading days from the disclosure [1]